Related content

Angiotensin-converting enzyme inhibitors: ischemia is not the correct measure of benefit

By Anderson H.V.  

Journal of the American College of Cardiology, Vol. 42, Iss. 12, 2003-12 ,pp. : 2060-2062

Elsevier

Access to resources Recommend Favorite

The Role of Angiotensin-Converting Enzyme in Blood Pressure Control, Renal Function, and Male Fertility - The production and persistent elevation of systolic blood pressure by means of renal ischemia

By Esther C.R.   Marino E.M.   Bernstein K.E.  

Trends in Endocrinology and Metabolism, Vol. 8, Iss. 5, 1997-07 ,pp. : 181-186

Elsevier

Access to resources Recommend Favorite

Effects of Angiotensin-Converting Enzyme Inhibitor on Delayed-Onset Doxorubicin-Induced Cardiotoxicity

By Boucek Robert J.   Steele Ann   Miracle Ann   Atkinson James  

Cardiovascular Toxicology, Vol. 3, Iss. 4, 2003-12 ,pp. : 319-330

Humana Press, Inc

Access to resources Recommend Favorite

Effects of Angiotensin-Converting Enzyme Inhibitory Peptide LAP on Vascular Remodeling

By Huang Junling   Luo Ming   Fang Hong   Zheng Huan   Shen Yi   Li Lingxia   Deng Yuqing   Xu Huifeng  

Clinical and Experimental Hypertension, Vol. 35, Iss. 6, 2013-10 ,pp. : 437-443

Informa Healthcare

Access to resources Recommend Favorite

Is Combined Angiotensin-converting Enzyme Inhibition and Angiotensin Receptor Blockade Associated with Increased Risk of Cardiovascular Death in Hemodialysis Patients?

By  

Current Hypertension Reviews, Vol. 8, Iss. 4, 2012-11 ,pp. : 256-266

Bentham Science Publishers

Access to resources Recommend Favorite